Shifa International HospitalsKAR:SHFA +2.14%85 EBITDA Margin % is 18.00% as of Mar. 2026, which is 16% above its 10-year median of 15.51. GuruFocus rates KAR:SHFA with a GF Score™ of 85/100 and a GF Value™ of ₨453.79 (Modestly Overvalued). Among 668 Healthcare Providers & Services companies, Shifa International Hospitals ranks better than 72.46% on this metric.
Shifa International Hospitals (KAR:SHFA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shifa International Hospitals EBITDA Margin % Related Terms
Shifa International Hospitals EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shifa International Hospitals EBITDA Margin % Chart
KAR:SHFA vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Shifa International Hospitals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shifa International Hospitals EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shifa International Hospitals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shifa International Hospitals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shifa International Hospitals (KAR:SHFA) has a EBITDA Margin % of 18.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shifa International Hospitals and its competitors. This is 16% above median its historical median of 15.51. Over the past decade, Shifa International Hospitals' EBITDA Margin % has ranged from 12.60 to 19.45. According to the industry distribution chart, Shifa International Hospitals ranks #184 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 27.5%.
Is Shifa International Hospitals' EBITDA Margin % too high?
Shifa International Hospitals' current EBITDA Margin % of 18.00% is 16% above median its 10-year median of 15.51. Over the past 10 years, this metric has ranged from a low of 12.60 to a high of 19.45. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Shifa International Hospitals' value of 18.00% is 76.3% above this industry median. Based on the distribution chart, Shifa International Hospitals ranks #184 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shifa International Hospitals has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shifa International Hospitals' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shifa International Hospitals ranks #184 out of 668 companies for EBITDA Margin %. This puts Shifa International Hospitals in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Shifa International Hospitals' value of 18.00% is 76.3% above this benchmark. Historically, Shifa International Hospitals' own EBITDA Margin % has ranged from 12.60 to 19.45 over the past decade. While the company's 10-year median is 15.51 vs. the industry median of 10.21, Shifa International Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shifa International Hospitals's current EBITDA Margin % of 18.00% is 76.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shifa International Hospitals and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shifa International Hospitals's current EBITDA Margin % is 18.00%, which is 16% above median its own 10-year median of 15.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shifa International Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Shifa International Hospitals (KAR:SHFA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨453.79, compared to a current price of ₨520.98 — trading 14.8% above its estimated fair value. The current EBITDA Margin % is 18.00%, which is 16% above median its 10-year median of 15.51 and 76.3% above the Healthcare Providers & Services industry median of 10.21. Shifa International Hospitals' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shifa International Hospitals (KAR:SHFA), the current EBITDA Margin % is 18.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shifa International Hospitals (KAR:SHFA) Overvalued in 2026?
Based on GuruFocus' analysis, Shifa International Hospitals stock appears to be overvalued.
The current stock price of ₨520.98 is trading 14.8% above its estimated GF Value™ of ₨453.79.
GuruFocus considers Shifa International Hospitals to be Modestly Overvalued.
Key valuation signals for KAR:SHFA:
EBITDA Margin %: 18.00% (16% above median its 10-year median of 15.51)
GF Value™: ₨453.79 vs. price of ₨520.98 (14.8% above fair value)
Industry Position: 76.3% above the Healthcare Providers & Services median (#184 of 668)
No single metric tells the full story. See the KAR:SHFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shifa International Hospitals Business Description
Shifa International Hospitals Ltd operates a network of medical centers and hospitals in Pakistan, providing a wide range of medical and surgical services across various specialties. The company offers organ transplant services, including liver, kidney, bone marrow, and corneal transplants. It generates revenue through patient care services, diagnostics, pharmacy operations, and support services such as emergency care and outpatient clinics. Shifa also operates lab collection points, day care surgeries, and diagnostic centers. The company has a presence in multiple cities through hospitals, medical centers, and subsidiaries that support healthcare services and infrastructure development.
85GF Score
Get the complete analysis for KAR:SHFA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:SHFA has been successfully added to your 
